Mycovia Pharmaceuticals Inc.
Clinical trials sponsored by Mycovia Pharmaceuticals Inc., explained in plain language.
-
New pill could stop yeast infections from coming back
Disease control CompletedThis study tested a new oral medication, oteseconazole, to see if it can prevent recurrent yeast infections in women who have had at least three episodes in the past year. Participants first received standard treatment for their current infection, then took either the study drug …
Phase: PHASE3 • Sponsor: Mycovia Pharmaceuticals Inc. • Aim: Disease control
Last updated May 26, 2026 18:01 UTC
-
New pill could keep yeast infections away for nearly a year
Disease control CompletedThis study tested a new oral medication, oteseconazole, in 425 women who have frequent yeast infections (at least 3 in the past year). Participants first received standard treatment for their current infection, then took either oteseconazole or a placebo daily for 12 weeks. The g…
Phase: PHASE3 • Sponsor: Mycovia Pharmaceuticals Inc. • Aim: Disease control
Last updated May 26, 2026 12:03 UTC